Aura Biosciences Net Income

The latest net income for AURA is $-130M as of June 2026. That compares with $-100M in the prior-year period — down 29.2% year over year. That is below the sector sector average of $87M. Investors often review this figure alongside Aura Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, AURA's net income moved from $-100M to $-130M — a 29.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aura Biosciences's operating scale or balance-sheet position.

Against its sector companies, AURA currently prints $-130M for net income, while the sector average sits near $87M. That is roughly 251.4% below the sector mean. Large gaps often invite a closer look at Aura Biosciences's growth, margins, and balance sheet.

A net income figure of $-130M for AURA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $87M. Explore the charts below for those layers of context.

After noting AURA's net income ($-130M), review year-over-year change from $-100M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.